KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

West Pharmaceutical Services (WST) Goodwill (2016 - 2025)

West Pharmaceutical Services' Goodwill history spans 17 years, with the latest figure at $110.6 million for Q3 2025.

  • For Q3 2025, Goodwill rose 1.65% year-over-year to $110.6 million; the TTM value through Sep 2025 reached $110.6 million, up 1.65%, while the annual FY2024 figure was $106.0 million, 2.3% down from the prior year.
  • Goodwill for Q3 2025 was $110.6 million at West Pharmaceutical Services, roughly flat from $110.9 million in the prior quarter.
  • Across five years, Goodwill topped out at $110.9 million in Q2 2025 and bottomed at $104.0 million in Q3 2022.
  • The 5-year median for Goodwill is $108.0 million (2023), against an average of $108.1 million.
  • The largest annual shift saw Goodwill fell 4.5% in 2022 before it grew 3.36% in 2025.
  • A 5-year view of Goodwill shows it stood at $109.9 million in 2021, then decreased by 2.37% to $107.3 million in 2022, then rose by 1.12% to $108.5 million in 2023, then decreased by 2.3% to $106.0 million in 2024, then grew by 4.34% to $110.6 million in 2025.
  • Per Business Quant, the three most recent readings for WST's Goodwill are $110.6 million (Q3 2025), $110.9 million (Q2 2025), and $107.5 million (Q1 2025).